id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-P-2236-0004,FDA,FDA-2020-P-2236,Final Response to Covington & Burling LLP from FDA CDER,Other,Agency Response,2022-12-30T05:00:00Z,2022,12,2022-12-30T05:00:00Z,,2022-12-30T18:35:24Z,,0,0,0900006485569c1f
FDA-2020-P-2236-0003,FDA,FDA-2020-P-2236,Response Letter from FDA CDER to Covington & Burling LLP,Other,Response(s),2021-05-24T04:00:00Z,2021,5,2021-05-24T04:00:00Z,,2021-05-24T14:41:33Z,,0,0,0900006484b2edd0
FDA-2020-P-2236-0002,FDA,FDA-2020-P-2236,Acknowledgment Letter from FDA DMS to Covington & Burling LLP on behalf of Pharmaceutical Research and Manufacturers of America,Other,Acknowledgement Letter/Receipt,2020-11-27T05:00:00Z,2020,11,2020-11-27T05:00:00Z,,2020-11-27T16:31:18Z,,0,0,0900006484979278
FDA-2020-P-2236-0001,FDA,FDA-2020-P-2236,"Citizen Petition from Covington & Burling, LLP on behalf of Pharmaceutical Research and Manufacturers of America",Other,Citizen Petition,2020-11-27T05:00:00Z,2020,11,2020-11-27T05:00:00Z,,2022-12-30T18:27:12Z,,0,0,0900006484979277